Skip to main content
Clinical Trials/NCT02627599
NCT02627599
Completed
Not Applicable

A Study to Evaluate Improvement in the Quality of Life and Health and Economic Outcomes of Patients Diagnosed With Chronic Obstructive Pulmonary Disease (COPD)

StratiHealth3 sites in 1 country35 target enrollmentMay 2015
ConditionsCOPD

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
COPD
Sponsor
StratiHealth
Enrollment
35
Locations
3
Primary Endpoint
Six Minute Walk Distance
Status
Completed
Last Updated
7 years ago

Overview

Brief Summary

  • Evaluate subjects in an prospective observational study

  • Subjects will be administered scientifically validated questionnaires

  • Evaluate Quality Improvement and Oxygen Utilization Improvements.

    1. Functional capability, dyspnea, oxygen saturation as primary endpoints
    2. Baseline Dyspnea Index (BDI)
    3. Transitional Dyspnea Index (TDI)
    4. Chronic Respiratory Disease Questionnaire (CRQ)
    5. Six minute walk distance (6MWD)
    6. Oxygen saturation using pulse oximeter
  • The secondary endpoints:

    1. Portable oxygen source utilization
    2. Health care utilization (emergency room encounters, hospital admissions)

Detailed Description

Evaluate subjects in an prospective observational study in which subjects will be screened and administered scientifically validated questionnaires at study entry and during the observation period at specified intervals to determine Quality Improvements through using the Breath Responsive Variable Bolus Oxygen Conserving Device with a Portable/Ambulatory Oxygen Source on improvements in functional capability, dyspnea, oxygen saturation, quality of life as primary endpoints, and portable oxygen source utilization, health care utilization as secondary endpoints.

Registry
clinicaltrials.gov
Start Date
May 2015
End Date
November 2016
Last Updated
7 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
StratiHealth
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Primary diagnosis of chronic obstructive pulmonary disease (COPD)
  • Clinically stable disease at the time of consent
  • Current prescription of oxygen 24 hours a day
  • Previous or current oximetry desaturation at rest or activity (≤88% on one occasion)
  • Highest measured FEV1, 70% predicted; and
  • Highest measured FEV1/FVC, 70% predicted
  • Capable of giving informed consent
  • Currently using a portable oxygen source that is a portable tank
  • Mobility without a walker, cane or rollator
  • Spo2 ≥ 90% on portable oxygen source at rest and activity

Exclusion Criteria

  • Cardiovascular disease - New York Heart Association Functional Class III
  • Degenerative bone or joint disease with limited functional ability
  • Current homeless persons
  • Active drug/alcohol dependence
  • Recent drug or alcohol abuse history within the past two years
  • Clinically unstable at the time of consent
  • Currently a tobacco smoker

Outcomes

Primary Outcomes

Six Minute Walk Distance

Time Frame: At baseline upon study entry and change from baseline every two weeks up to three months

Assess distance covered in meters at baseline over 6 minutes and every two weeks up to three months to determine improvement in functional capability

Transition Dyspnea Index (TDI)

Time Frame: Every two weeks after baseline up to three months

Improvement in Functional Capability, Dyspnea as measured with the Transition Dyspnea Index (TDI)

Oxygen Saturation

Time Frame: At baseline upon study entry and change from baseline every two weeks up to three months

Assess pulse oximetry saturation at baseline on setting to maintain oxygen saturation equal to or greater than 90% at rest and with activity every two weeks to determine improvement or equivalence

Baseline Dyspnea Index (BDI)

Time Frame: At baseline once upon entry into the study

Baseline Functional Capability, Dyspnea as measured with the Baseline Dyspnea Index (BDI)

Chronic Respiratory Disease Questionnaire (CRQ)

Time Frame: At baseline upon study entry and change from baseline every two weeks up to three months

Improvement in Quality of Life as measured with the Chronic Respiratory Disease Questionnaire

Secondary Outcomes

  • Portable Oxygen Source Utilization(6 Months)
  • Healthcare Utilization(6 Months)

Study Sites (3)

Loading locations...

Similar Trials